Autolus Therapeutics PLC (NAS:AUTL)
$ 3.835 -0.005 (-0.13%) Market Cap: 1.02 Bil Enterprise Value: 314.39 Mil PE Ratio: 0 PB Ratio: 1.75 GF Score: 55/100

Autolus Therapeutics PLC To Discuss the ASH data Transcript

Dec 13, 2021 / 01:00PM GMT
Release Date Price: $5.98 (-12.95%)
Operator

Hello, ladies and gentlemen. I am pleased to welcome to the Autolus Therapeutics ASH 2021 Investor Conference Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, VP Business Strategy and Planning at Autolus. Please go ahead.

Lucinda Crabtree
Autolus Therapeutics plc - VP of IR, Corporate Communications, Business Strategy & Planning

Thank you. Good morning or good afternoon, everyone, and thank you for joining us and taking part in today's call covering the data we have presented over the weekend at the American Society of Hematology or ASH Conference being held in Atlanta.

I'm Lucinda Crabtree, VP Business Strategy and Planning, and I'm joined today by Dr. Christian Itin, our CEO; Dr. Edgar Braendle, our Chief Development Officer; Dr. Wolfram Brugger, our Chief -- our Head of Clinical Development; Dr. Martin Pule, our Chief Scientific Officer; and Andrew Oakley, our CFO.

Before I pass you to Christian for his introduction and opening remarks, I'd

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot